In vitro nuclear interactome of the HIV-1 Tat protein

Abstract

Background: One facet of the complexity underlying the biology of HIV-1 resides not only in its limited number of viral proteins, but in the extensive repertoire of cellular proteins they interact with and their higher-order assembly. HIV-1 encodes the regulatory protein Tat (86-101aa), which is essential for HIV-1 replication and primarily orchestrates HIV-1 provirus transcriptional regulation. Previous studies have demonstrated that Tat function is highly dependent on specific interactions with a range of cellular proteins. However they can only partially account for the intricate molecular mechanisms underlying the dynamics of proviral gene expression. To obtain a comprehensive nuclear interaction map of Tat in T-cells, we have designed a proteomic strategy based on affinity chromatography coupled with mass spectrometry.Results: Our approach resulted in the identification of a total of 183 candidates as Tat nuclear partners, 90% of which have not been previously characterised. Subsequently we applied in silico analysis, to validate and characterise our dataset which revealed that the Tat nuclear interactome exhibits unique signature(s). First, motif composition analysis highlighted that our dataset is enriched for domains mediating protein, RNA and DNA interactions, and helicase and ATPase activities. Secondly, functional classification and network reconstruction clearly depicted Tat as a polyvalent protein adaptor and positioned Tat at the nexus of a densely interconnected interaction network involved in a range of biological processes which included gene expression regulation, RNA biogenesis, chromatin structure, chromosome organisation, DNA replication and nuclear architecture. Conclusion:We have completed the in vitro Tat nuclear interactome and have highlighted its modular network properties and particularly those involved in the coordination of gene expression by Tat. Ultimately, the highly specialised set of molecular interactions identified will provide a framework to further advance our understanding of the mechanisms of HIV-1 proviral gene silencing and activation.

High Levels of CD2 Expression Identify HIV-1 Latently Infected Resting Memory CD4+T Cells in Virally Suppressed Subjects

“…However, mRNAs of the HIV-1 receptor CD4 and coreceptor CXCR4 genes were upregulated in these cells. Transcripts of factors involved in RNA splicing (PRPF4B, SFRS16, and SFRS17A) were upregulated in latently infected cells, whereas factors mediating nuclear import of Rev (IPO5/RANBP5 [38] and IPO7 [39]) and Tat (NUP93 and NUP153 [40]) were downmodulated in these cells.…”

Protein intrinsic disorder as a flexible armor and a weapon of HIV-1

“…Tat has been shown to regulate the capping of HIV-1 mRNA [269], to interact with Dicer and suppress the production of small interfering RNA [270], and to act as a nucleic acid chaperone [271]. Recently, 183 proteins within the nucleus of Jurkat T cells were found to be cellular targets of Tat [272]. The identified nuclear targets covered a range of biological processes: transcription, RNA processing, translation, nuclear organization, cell cycle, DNA replication, and signaling, with transcription being the most highly represented process (39%).…”

Identification of putative biomarkers for HIV-associated neurocognitive impairment in the CSF of HIV-infected patients under cART therapy determined by mass spectrometry

“…For example, orosomucoid inhibits the infection of human monocyte-derived macrophages by R5 HIV-1 (Atemezem et al 2001; Rabehi et al 1995). Gautier et al have shown that ruvB-like2 is one of the 183 Jurkat T cell nuclear extract proteins that interact with Tat (Gautier et al 2009). In a similar study, Impens et al incubated HIV-1 protease with Jurkat T cell lysates and analyzed the resulting peptides with MS (Impens et al 2012).…”